BRITTANY GUTHRIE: Open Payments
NPI 1003288648 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 25 payments from 11 companies in 2025. Trend: 2023 $161 · 2024 $315 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $206 |
| Eisai Inc. | 2 | $127 |
| ACADIA Pharmaceuticals Inc | 3 | $67 |
| TG Therapeutics, Inc. | 3 | $55 |
| Genentech USA, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Cycle Pharmaceuticals Inc | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| Neurelis, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: Leqembi, BOTOX, QULIPTA, NUPLAZID, UBRELVY, BRIUMVI, Ocrevus Zunovo, KISUNLA.
Industry payments across ID — which companies pay providers there.
